分娩及围产期催产素的生理学与药理学
催产素是参与分娩过程的生殖激素,广泛用于产程中。本文综述其生理释放机制、受体作用、对前列腺素合成的影响及中枢效应,并总结合成催产素的给药方案、血药浓度变化、对产程时长和剖宫产率的影响及安全性注意事项。
要点
- 催产素在下丘脑视上核和室旁核产生,从垂体后叶释放入循环,第一和第二产程脉冲频率和幅度增加。
- 合成催产素可按不同剂量方案给药,从1至3 mIU/min递增至最大36 mIU/min,间隔15至40分钟。
- 推荐剂量水平的合成催产素不太可能穿过胎盘或母体血脑屏障,高剂量可能引起子宫过度刺激。
核心结论
- 催产素在分娩中既有生理作用,也作为药物用于引产和加强宫缩;高剂量输注可能缩短产程最长2小时,但不降低剖宫产频率。
研究设计与样本
- 综述,检索范围未在原文中报告。
主要发现
- 催产素以脉冲形式释放,第一和第二产程脉冲频率和幅度增加,第三产程仅少数脉冲。
- 胎儿对子宫颈施压激活弗格森反射释放催产素;子宫肌层收缩激活交感神经则减少催产素释放。
- 催产素结合子宫肌层特异性受体诱导收缩,足月时高循环雌激素使受体更敏感。
- 催产素激活特异性受体刺激蜕膜和绒毛膜羊膜前列腺素合成与释放,前列腺素促进宫颈成熟和子宫收缩。
- 高剂量输注催产素相比不输注可缩短产程最长2小时,但不降低剖宫产频率。
关键数值与推荐
- 合成催产素可按不同剂量方案给药,从1至3 mIU/min递增至最大36 mIU/min,间隔15至40分钟。
- 分娩期间给予合成催产素总量可为5至10 IU,也可给予更低或更高剂量。
- 输注速率20至30 mIU/min时,血浆催产素浓度较基础水平升高约2至3倍。
- 产后常常规静脉或肌内注射5至10 IU合成催产素以诱导子宫收缩、促进胎盘剥离和排出并预防产后出血。
临床怎么用
- 合成催产素应以推荐剂量水平给药,高剂量可能引起子宫收缩过速和子宫过度刺激,对胎儿和母体可能有不良后果。
- 产后可常规给予5至10 IU合成催产素静脉或肌内注射以预防产后出血并促进胎盘排出。
局限性
- 研究提示但尚未证实分娩可能与母婴长期行为和生理适应有关,可能涉及催产素产生、释放及受体的表观遗传调控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oxytocin is a reproductive hormone implicated in the process of parturition and widely used during labor. Oxytocin is produced within the supraoptic nucleus and paraventricular nucleus of the hypothalamus and released from the posterior pituitary lobe into the circulation. Oxytocin is released in pulses with increasing frequency and amplitude in the first and second stages of labor, with a few pulses released in the third stage of labor. During labor, the fetus exerts pressure on the cervix of the uterus, which activates a feedforward reflex-the Ferguson reflex-which releases oxytocin. When myometrial contractions activate sympathetic nerves, it decreases oxytocin release. When oxytocin binds to specific myometrial oxytocin receptors, it induces myometrial contractions. High levels of circulating estrogen at term make the receptors more sensitive. In addition, oxytocin stimulates prostaglandin synthesis and release in the decidua and chorioamniotic membranes by activating a specific type of oxytocin receptor. Prostaglandins contribute to cervical ripening and uterine contractility in labor. The oxytocin system in the brain has been implicated in decreasing maternal levels of fear, pain, and stress, and oxytocin release and function during labor are stimulated by a social support. Moreover, studies suggest, but have not yet proven, that labor may be associated with long-term, behavioral and physiological adaptations in the mother and infant, possibly involving epigenetic modulation of oxytocin production and release and the oxytocin receptor. In addition, infusions of synthetic oxytocin are used to induce and augment labor. Oxytocin may be administered according to different dose regimens at increasing rates from 1 to 3 mIU/min to a maximal rate of 36 mIU/min at 15- to 40-minute intervals. The total amount of synthetic oxytocin given during labor can be 5 to 10 IU, but lower and higher amounts of oxytocin may also be given. High-dose infusions of oxytocin may shorten the duration of labor by up to 2 hours compared with no infusion of oxytocin; however, it does not lower the frequency of cesarean delivery. When synthetic oxytocin is administered, the plasma concentration of oxytocin increases in a dose-dependent way: at infusion rates of 20 to 30 mIU/min, plasma oxytocin concentration increases approximately 2- to 3-fold above the basal level. Synthetic oxytocin administered at recommended dose levels is not likely to cross the placenta or maternal blood-brain barrier. Synthetic oxytocin should be administered with caution as high levels may induce tachystole and uterine overstimulation, with potentially negative consequences for the fetus and possibly the mother. Of note, 5 to 10 IU of synthetic oxytocin is often routinely given as an intravenous or intramuscular bolus administration after delivery to induce uterine contractility, which, in turn, induces uterine separation of the placenta and prevents postpartum hemorrhage. Furthermore, it promotes the expulsion of the placenta.
引用
- Uvnäs-Moberg K. The physiology and pharmacology of oxytocin in labor and in the peripartum period. Am J Obstet Gynecol. 2023. PMID: 38462255. doi:10.1016/j.ajog.2023.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。